Stay updated on Durvalumab Efficacy in Stage II-III NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Efficacy in Stage II-III NSCLC Clinical Trial page.

Latest updates to the Durvalumab Efficacy in Stage II-III NSCLC Clinical Trial page
- Check6 days agoChange DetectedThe history now lists revision v3.6.5, replacing the previous v3.6.4, indicating a new page version was published.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe Record History now shows Revision: v3.6.4, replacing the previous Revision: v3.6.3, indicating a minor update to the page’s historical record.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check42 days agoChange DetectedThe history now adds Revision: v3.6.3 and removes Revision: v3.6.2, updating the page's revision trail.SummaryDifference0.1%

- Check49 days agoChange DetectedThe record history now shows a new Revision: v3.6.2 entry, replacing the previous Revision: v3.6.0 entry. This reflects an update to the versioning information in the study record and is a non-substantive UI/metadata change.SummaryDifference0.1%

- Check63 days agoChange DetectedThe study record now shows that recruitment is closed for participants, and the history adds a new revision label v3.6.0 while removing the previous v3.5.5 tag.SummaryDifference0.3%

- Check70 days agoChange DetectedThe history includes a new revision tag v3.5.5, replacing v3.5.4, indicating an updated build of the page.SummaryDifference0.1%

Stay in the know with updates to Durvalumab Efficacy in Stage II-III NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Efficacy in Stage II-III NSCLC Clinical Trial page.